We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+7.4%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$471B
AUM Growth
+$12.9B
Cap. Flow
-$11.2B
Cap. Flow %
-2.38%
Top 10 Hldgs %
12.86%
Holding
2,627
New
87
Increased
929
Reduced
999
Closed
89

Top Sells

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$1.73B
2
ECL icon
Ecolab
ECL
+$1.17B
3
CCI icon
Crown Castle
CCI
+$906M
4
PSX icon
Phillips 66
PSX
+$775M
5
GILD icon
Gilead Sciences
GILD
+$756M

Sector Composition

Rank Sector Weight
1 Healthcare 19.84%
2 Consumer Discretionary 13.93%
3 Financials 13.41%
4 Industrials 12.4%
5 Technology 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OLN icon
2001
Olin
OLN
$2.17B
$435K ﹤0.01%
19,090
POWI icon
2002
Power Integrations
POWI
$3.48B
$435K ﹤0.01%
16,800
BOBE
2003
DELISTED
Bob Evans Farms, Inc.
BOBE
$435K ﹤0.01%
8,500
CNMD icon
2004
CONMED
CNMD
$1.49B
$434K ﹤0.01%
9,650
FNB icon
2005
FNB Corp
FNB
$6.88B
$434K ﹤0.01%
32,606
ACH
2006
Accendra Health
ACH
$83.8M
$432K ﹤0.01%
12,300
INDB icon
2007
Independent Bank
INDB
$4.05B
$430K ﹤0.01%
10,050
EBIX
2008
DELISTED
Ebix Inc
EBIX
$430K ﹤0.01%
25,302
KFY icon
2009
Korn Ferry
KFY
$4.35B
$429K ﹤0.01%
14,900
-5,800
-28% -$158K
ALX
2010
Alexander's
ALX
$1.4B
$428K ﹤0.01%
980
+100
+11% +$41.5K
MRC
2011
DELISTED
MRC Global
MRC
$426K ﹤0.01%
28,100
-9,000
-24% -$175K
ABM icon
2012
ABM Industries
ABM
$2.82B
$425K ﹤0.01%
14,850
FFIC
2013
DELISTED
Flushing Financial
FFIC
$423K ﹤0.01%
20,875
+2,500
+14% +$48.8K
MSTR icon
2014
Strategy Inc
MSTR
$38.2B
$423K ﹤0.01%
26,060
KALU icon
2015
Kaiser Aluminum
KALU
$2.99B
$421K ﹤0.01%
5,900
TMP icon
2016
Tompkins Financial
TMP
$1.45B
$421K ﹤0.01%
7,611
-300
-4% -$14.8K
MTOR
2017
DELISTED
MERITOR, Inc.
MTOR
$421K ﹤0.01%
27,800
CTWS
2018
DELISTED
Connecticut Water Service Inc
CTWS
$419K ﹤0.01%
11,550
+800
+7% +$28.1K
SMLR
2019
DELISTED
Semler Scientific
SMLR
$418K ﹤0.01%
213,077
+100
+0% +$240
AGU
2020
DELISTED
Agrium
AGU
$418K ﹤0.01%
4,400
-629,961
-99% -$59M
LKFN icon
2021
Lakeland Financial Corp
LKFN
$1.56B
$417K ﹤0.01%
14,400
+3,750
+35% +$101K
BAC.PRL icon
2022
Bank of America Series L
BAC.PRL
$4.01B
$416K ﹤0.01%
361
-110
-23% -$127K
NWLIA
2023
DELISTED
NATL WESTN LIFE INS CO CL A
NWLIA
$415K ﹤0.01%
1,540
+130
+9% +$35K
NSP icon
2024
Insperity
NSP
$2.05B
$412K ﹤0.01%
24,300
SWFT
2025
DELISTED
Swift Transportation Company
SWFT
$412K ﹤0.01%
14,400
+2,600
+22% +$66.3K

Similar funds

T. Rowe Price Associates's Q4 2014 Portfolio in Review

As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
  • T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
  • T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
  • T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
  • T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
  • T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
  • T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.

Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.